The company has gradually entered new business areas in recently years to seek growth points for sustainable development, creating an industrial chain multi-industry development model, and focusing on investment in high-value-added pharmaceutical raw materials and high-end pharmaceutical intermediates. The relevant development direction of the company stimulates the vitality of innovation and development of invested-enterprises, and empowers the core competitiveness of invested-enterprises.
It is our mission to reduce the pain of disease and improve the sense of happiness life. As a member of China's pharmaceutical raw material industry, its are the main themes we believe in to keep our invested-enterprises green chemical, environmental protection and sustainable development; to promote and guide invested-enterprises to become large pharmaceutical enterprises that innovate in research strengthen APIs, and develop finished preparations.